CAPDM Welcomes Lundbeck Canada

Lundbeck Canada

Lundbeck Canada has been striving to improve the lives of Canadians with psychiatric and neurological diseases since 1995. As a subsidiary of H. Lundbeck A/S, a global biopharmaceutical company focusing exclusively on brain health, we benefit from over 70 years of experience in neuroscience. We’re advancing brain health to transform lives.

As a focused innovator, our research and development programs tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few to no treatments available and are committed to advancing brain health by curiously exploring new opportunities for treatments. We are committed to fighting stigma and we act to improve health equity, striving to create long term value by making a positive contribution to patients, their families and society as a whole.

For more information, please visit: www.lundbeck.com/ca/en